hydroxyurea has been researched along with Granulocytic Leukemia, Chronic, Stable Phase in 49 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Overexpression of P-170 without amplification of MDR-1 was found in four of 11 patients with chronic phase CML at diagnosis, seven of 16 patients treated with busulfan or hydroxyurea in chronic phase and four of 15 patients in blast crisis." | 3.68 | The role of the MDR-1/P-170 mechanism in the development of multidrug resistance in chronic myeloid leukemia. ( Dowding, C; Goldman, J; Paulsen, W; Weide, R, 1990) |
| "Forty-eight patients with chronic myeloid leukemia (CML) in chronic phase (CP) were treated by autologous stem cells transplantation (ASCT) and alpha Interferon (IFN) with three approaches: 1) ASCT at diagnosis followed by IFN, 2) ASCT post IFN with cells collected after an interval from IFN discontinuance, followed by IFN, 3) ASCT in patients selected by cytoconversion obtained with IFN, performed soon after IFN discontinuance." | 2.67 | Management of chronic myeloid leukemia in chronic phase with autologous stem cell transplantation and alpha-2 interferon: cytogenetic and clinical results. ( Alimena, G; Cedrone, M; de Cuia, MR; Lo Coco, F; Mancini, M; Meloni, G; Montefusco, E; Nanni, M; Pinto, R; Rondinelli, MB, 1993) |
| "The clinical course of 196 patients with chronic myelocytic leukemia (CML) was studied." | 2.67 | [Evaluation of 196 patients with chronic myeloid leukemia based on a standard prognosis model]. ( Anger, B; Carbonell, F; Ganser, A; Heimpel, H; Robertson, J; Schmeiser, T; Sokal, JE, 1990) |
| "Leukemic cells from many patients with acute myelogenous leukemia (AML) have surface receptors for CSFs and may proliferate in response to CSFs." | 2.40 | Cytokine therapy for hematological malignancies. ( Ezaki, K; Tsuzuki, M, 1997) |
| "Hydroxyurea treated patients had lower expression of IGF-IR in granulocytes, lymphocytes and monocytes (P<0." | 1.31 | Interferon-alpha therapy increases type I insulin-like growth factor receptors expression on lymphoid cells from patients with chronic myelogenous leukemia. ( Bendit, I; Dorlhiac-Lacer, P; Giannella-Neto, D; Ohnuma, L; Oliveira, MR, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.04) | 18.7374 |
| 1990's | 21 (42.86) | 18.2507 |
| 2000's | 20 (40.82) | 29.6817 |
| 2010's | 7 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rinaldi, I | 1 |
| Reksodiputro, AH | 1 |
| Jusman, SW | 1 |
| Harahap, A | 1 |
| Setiabudy, R | 1 |
| Wanandi, SI | 1 |
| Tambunan, K | 1 |
| Suharti, C | 1 |
| Ferri, CA | 1 |
| Bianchini, M | 1 |
| Bengió, RM | 1 |
| Moiraghi, EB | 1 |
| Gonzalez, MS | 1 |
| Noriega, MF | 1 |
| Larripa, IB | 1 |
| Lovato, S | 1 |
| Ayto, R | 1 |
| Stagno, F | 2 |
| Vigneri, P | 2 |
| Del Fabro, V | 1 |
| Stella, S | 1 |
| Berretta, S | 1 |
| Massimino, M | 1 |
| Tirrò, E | 1 |
| Messina, A | 1 |
| Di Raimondo, F | 1 |
| Tolo-Diebkilé, A | 1 |
| Koffi, KG | 1 |
| Sawadogo, GD | 1 |
| Ndiaye, FS | 1 |
| Nanho, DC | 1 |
| Sékongo, YM | 1 |
| Kouakou, B | 1 |
| Méité, N | 1 |
| Ayemou, R | 1 |
| Sanogo, I | 1 |
| Ganesan, P | 1 |
| Sagar, TG | 1 |
| Dubashi, B | 1 |
| Rajendranath, R | 1 |
| Kannan, K | 1 |
| Cyriac, S | 1 |
| Nandennavar, M | 1 |
| Kobayashi, Y | 1 |
| Tanaka, T | 1 |
| Kawata, E | 1 |
| Akaogi, T | 1 |
| Roy, L | 1 |
| Tomowiak, C | 1 |
| Guilhot, F | 3 |
| Helmann, R | 1 |
| Berger, U | 2 |
| Engelich, G | 1 |
| Kühr, T | 1 |
| Burgstaller, S | 1 |
| Apfelbeck, U | 1 |
| Linkesch, W | 1 |
| Seewann, H | 1 |
| Fridrik, M | 1 |
| Michlmayr, G | 1 |
| Krieger, O | 1 |
| Lutz, D | 1 |
| Lin, W | 1 |
| Pont, J | 1 |
| Köck, L | 1 |
| Abbrederis, K | 1 |
| Baldinger, C | 1 |
| Buder, R | 1 |
| Geissler, D | 1 |
| Hausmaninger, H | 1 |
| Lang, A | 1 |
| Zabernigg, A | 1 |
| Duba, C | 1 |
| Hilbe, W | 1 |
| Eisterer, W | 1 |
| Fiegl, M | 2 |
| Greil, R | 1 |
| Gastl, G | 1 |
| Thaler, J | 1 |
| Royer-Pokora, B | 1 |
| Hildebrandt, B | 1 |
| Redmann, A | 1 |
| Herold, C | 1 |
| Kronenwett, R | 1 |
| Haas, R | 1 |
| Drechsler, M | 1 |
| Wieland, C | 1 |
| Goldman, JM | 2 |
| Al-Zahrani, H | 1 |
| Gupta, V | 1 |
| Minden, MD | 1 |
| Messner, HA | 1 |
| Lipton, JH | 1 |
| Kiani, A | 1 |
| Habermann, I | 1 |
| Schäke, K | 1 |
| Neubauer, A | 1 |
| Rogge, L | 1 |
| Ehninger, G | 1 |
| Perel, JM | 1 |
| McCarthy, C | 1 |
| Walker, O | 1 |
| Irving, I | 1 |
| Williams, B | 1 |
| Kennedy, GA | 1 |
| Chen, SW | 1 |
| Hwang, WS | 1 |
| Tsao, CJ | 1 |
| Liu, HS | 1 |
| Huang, GC | 1 |
| Hagberg, A | 1 |
| Olsson-Strömberg, U | 1 |
| Wickenberg-Bolin, U | 1 |
| Göransson, H | 1 |
| Isaksson, A | 1 |
| Bengtsson, M | 1 |
| Höglund, M | 1 |
| Simonsson, B | 1 |
| Barbany, G | 1 |
| Breccia, M | 1 |
| Gentilini, F | 1 |
| Alimena, G | 2 |
| Meloni, G | 1 |
| de Cuia, MR | 1 |
| Rondinelli, MB | 1 |
| Lo Coco, F | 1 |
| Montefusco, E | 1 |
| Mancini, M | 1 |
| Pinto, R | 1 |
| Nanni, M | 1 |
| Cedrone, M | 1 |
| Nese, M | 2 |
| de Bellis, R | 1 |
| Urtiarte, R | 1 |
| Di Landro, J | 1 |
| Hehlmann, R | 5 |
| Heimpel, H | 4 |
| Kolb, HJ | 3 |
| Heinze, B | 2 |
| Hochhaus, A | 3 |
| Griesshammer, M | 3 |
| Pralle, H | 2 |
| Queisser, WP | 1 |
| Essers, U | 1 |
| Falge, C | 1 |
| Fernandez-Rañada, JM | 2 |
| Lavilla, E | 2 |
| Odriozola, J | 1 |
| Garcia-Laraña, J | 1 |
| Lozano, M | 1 |
| Parody, R | 1 |
| Giraldo, MP | 1 |
| Carbonell, F | 2 |
| Ferro, MT | 2 |
| Steegmann, JL | 2 |
| Johnson, RJ | 1 |
| Owen, RG | 1 |
| Child, JA | 1 |
| Morgan, GJ | 1 |
| Barnard, DL | 1 |
| Dickinson, H | 1 |
| Ricketts, S | 1 |
| Rawstron, A | 1 |
| Evans, P | 1 |
| Woodhead, V | 1 |
| Major, K | 1 |
| Robinson, F | 1 |
| Smith, GM | 1 |
| Marley, SB | 1 |
| Lewis, JL | 1 |
| Gordon, MY | 1 |
| Hossfeld, DK | 2 |
| Hasford, J | 1 |
| Löffler, H | 1 |
| Queisser, W | 1 |
| Tichelli, A | 1 |
| Fett, W | 1 |
| Schmitz, N | 1 |
| Reiter, A | 1 |
| Pfeifer, W | 1 |
| Bümler, M | 1 |
| Kamp, T | 1 |
| Tobler, A | 1 |
| Eimermacher, H | 1 |
| Kuse, R | 1 |
| Ansari, H | 1 |
| Guerci, A | 1 |
| Fiere, D | 1 |
| Harousseau, JL | 1 |
| Maloisel, F | 1 |
| Bouabdallah, R | 1 |
| Guyotat, D | 1 |
| Rochant, H | 1 |
| Najman, A | 1 |
| Nicolini, F | 1 |
| Colombat, P | 1 |
| Abgrall, JF | 1 |
| Ifrah, N | 1 |
| Brière, J | 1 |
| Bauters, F | 1 |
| Navarro, M | 1 |
| Morice, P | 1 |
| Bordessoule, D | 1 |
| Vilque, JP | 1 |
| Desablens, B | 1 |
| Tertian, G | 1 |
| Blanc, M | 1 |
| Chastang, C | 1 |
| Tanzer, J | 1 |
| Kattan, MW | 1 |
| Inoue, Y | 1 |
| Giles, FJ | 2 |
| Talpaz, M | 2 |
| Ozer, H | 1 |
| Zuffa, E | 1 |
| Huber, SL | 1 |
| Beck, JR | 1 |
| Jacob, A | 1 |
| Griffiths, M | 1 |
| Larkins, S | 1 |
| Holmes, J | 1 |
| Ezaki, K | 1 |
| Tsuzuki, M | 1 |
| Sacchi, S | 1 |
| Kantarjian, HM | 1 |
| O'Brien, S | 1 |
| Beran, M | 1 |
| Koller, C | 1 |
| Pierce, S | 1 |
| Kornblau, S | 1 |
| Estey, E | 1 |
| Keating, MJ | 1 |
| Chott, A | 1 |
| Seewann, HL | 1 |
| Lechner, K | 1 |
| Gisslinger, H | 1 |
| Shan, J | 1 |
| Chen, S | 1 |
| Advani, SH | 1 |
| Supandiman, I | 1 |
| Aziz, Z | 1 |
| Caviles, AP | 1 |
| Tee, GY | 1 |
| Chasen, MR | 1 |
| Fahed, Z | 1 |
| Chaoj, TY | 1 |
| Aydogdu, I | 1 |
| Lynott, AM | 1 |
| Schultheis, B | 2 |
| Pasternak, G | 2 |
| Heissig, B | 1 |
| Hörner, S | 1 |
| Oliveira, MR | 1 |
| Ohnuma, L | 1 |
| Bendit, I | 1 |
| Dorlhiac-Lacer, P | 1 |
| Giannella-Neto, D | 1 |
| Kvasnicka, HM | 1 |
| Thiele, J | 1 |
| Schmitt-Graeff, A | 1 |
| Diehl, V | 2 |
| Zankovich, R | 1 |
| Niederle, N | 1 |
| Leder, LD | 1 |
| Schaefer, HE | 1 |
| Ohnishi, K | 1 |
| Ino, T | 1 |
| Kishimoto, Y | 1 |
| Usui, N | 1 |
| Shimazaki, C | 1 |
| Ohtake, S | 1 |
| Taguchi, H | 1 |
| Kusumoto, S | 1 |
| Kuriyama, K | 1 |
| Hotta, T | 1 |
| Ohno, R | 1 |
| Maury, S | 1 |
| Belhadj, K | 1 |
| Chami, I | 1 |
| Kuentz, M | 1 |
| Cordonnier, C | 1 |
| Bories, D | 1 |
| Wassmann, B | 1 |
| Klein, SA | 1 |
| Scheuring, U | 1 |
| Pfeifer, H | 1 |
| Martin, H | 1 |
| Gschaidmeier, H | 1 |
| Hoelzer, D | 1 |
| Ottmann, OG | 1 |
| Matsuo, T | 1 |
| Tomonaga, M | 1 |
| Somolinos, N | 1 |
| Pérez-Sánchez, M | 1 |
| Lamana, M | 1 |
| Olmeda, F | 1 |
| Cámara, R | 1 |
| Arranz, R | 1 |
| Kelsey, PR | 1 |
| Liang, R | 1 |
| Chan, TK | 1 |
| Chiu, E | 1 |
| Todd, D | 1 |
| Anger, B | 1 |
| Schmeiser, T | 1 |
| Robertson, J | 1 |
| Sokal, JE | 1 |
| Ganser, A | 1 |
| Weide, R | 1 |
| Dowding, C | 1 |
| Paulsen, W | 1 |
| Goldman, J | 1 |
| Georgii, A | 1 |
| von Wussow, P | 1 |
| Jacobs, P | 1 |
| Wood, L | 1 |
| Foster, J | 1 |
6 reviews available for hydroxyurea and Granulocytic Leukemia, Chronic, Stable Phase
| Article | Year |
|---|---|
Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment.
Topics: Antineoplastic Agents; Benzamides; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 2; Clinical | 2003 |
Therapeutic strategies for chronic myeloid leukemia in the chronic (stable) phase.
Topics: Animals; Antineoplastic Agents; Benzamides; Enzyme Inhibitors; Hematopoietic Stem Cell Transplantati | 2003 |
Vascular events associated with alpha interferon therapy.
Topics: Adult; Antineoplastic Agents; Fatal Outcome; Female; Foot Ulcer; Gangrene; Hemolytic-Uremic Syndrome | 2003 |
Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia.
Topics: Antineoplastic Agents; Cost-Benefit Analysis; Decision Support Techniques; Humans; Hydroxyurea; Inte | 1996 |
Cytokine therapy for hematological malignancies.
Topics: Antineoplastic Agents; Busulfan; Clinical Trials as Topic; Cytokines; Follow-Up Studies; Granulocyte | 1997 |
[Chemotherapy and radiation therapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineopl | 2001 |
17 trials available for hydroxyurea and Granulocytic Leukemia, Chronic, Stable Phase
| Article | Year |
|---|---|
[Imatinib combination therapies--the new CML Study 4].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cytarabine; Dose-Response R | 2002 |
A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Gastrointestinal Di | 2003 |
Management of chronic myeloid leukemia in chronic phase with autologous stem cell transplantation and alpha-2 interferon: cytogenetic and clinical results.
Topics: Adult; Blood Component Transfusion; Blood Transfusion, Autologous; Bone Marrow; Bone Marrow Purging; | 1993 |
[Treatment of chronic myeloid leukemia using alpha-interferon and hydroxyurea. Study of 30 cases].
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Female; Fever; Humans; Hydroxyurea; Immunologic | 1994 |
The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1.
Topics: Adult; Busulfan; Female; Germany; Germany, West; Humans; Hydroxyurea; Immunologic Factors; Interfero | 1993 |
Interferon alpha 2A in the treatment of chronic myelogenous leukemia in chronic phase. Results of the Spanish Group.
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hydroxyurea; | 1993 |
Karyotypic conversion by interferon as preparative treatment for autologous BMT in Ph positive CML. Italian Cooperative Study Group (ICSG) on Chronic Myeloid Leukemia.
Topics: Adult; Bone Marrow Purging; Bone Marrow Transplantation; Combined Modality Therapy; Feasibility Stud | 1993 |
Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group.
Topics: Adult; Antineoplastic Agents; Clinical Protocols; Combined Modality Therapy; Female; Germany; Humans | 1996 |
The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group.
Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Cytarabine; Drug Tolerance; France; H | 1996 |
Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Follow- | 1997 |
A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the International Oncology Study Group CML1 study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Female; | 2000 |
Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial.
Topics: Antineoplastic Agents; Bone Marrow; Decision Trees; Female; Humans; Hydroxyurea; Interferon alpha-2; | 2001 |
Multicenter prospective study of interferon-alpha versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia: a preliminary analysis.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone | 2001 |
[Treatment with interferon alfa-2a in the chronic phase of Philadelphia-positive chronic myeloid leukemia].
Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Marrow Diseases; Combined Modality Therapy; Female; Human | 1992 |
[Evaluation of 196 patients with chronic myeloid leukemia based on a standard prognosis model].
Topics: Biomarkers, Tumor; Blast Crisis; Busulfan; Clinical Trials as Topic; Female; Follow-Up Studies; Huma | 1990 |
[Therapy of chronic myeloid leukemia with interferon, alone or combined. Preliminary experience].
Topics: Adolescent; Adult; Aged; Busulfan; Combined Modality Therapy; Female; Humans; Hydroxyurea; Immunolog | 1991 |
[Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)].
Topics: Busulfan; Female; Follow-Up Studies; Humans; Hydroxyurea; Interferon Type I; Leukemia, Myelogenous, | 1991 |
26 other studies available for hydroxyurea and Granulocytic Leukemia, Chronic, Stable Phase
| Article | Year |
|---|---|
Longer Hydroxyurea Administration Prior to Imatinib Mesylate is Risk Factor for Unsuccessful Major Molecular Response in Chronic-Phase Chronic Myeloid Leukemia: Possibility of P-Glycoprotein Role.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Membe | 2019 |
Clinical activity of ponatinib in one patient with chronic myeloid leukemia in chronic phase with e19a2 transcript and T315I mutation.
Topics: Antineoplastic Agents; Dasatinib; Drug Resistance, Neoplasm; Female; Fusion Proteins, bcr-abl; Gene | 2015 |
Haemolysis in female patient with chronic phase CML.
Topics: Asian People; Blood Transfusion; Female; Hemolysis; Humans; Hydroxyurea; Leukapheresis; Leukemia, My | 2017 |
Uncommon long-term survival in a patient with chronic myeloid leukemia.
Topics: Antineoplastic Agents; Busulfan; Female; Humans; Hydroxyurea; Immunosuppressive Agents; Leukemia, My | 2009 |
[Therapeutic impact of alpha interferon in chronic myelogenous leukaemia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Female; Fusion Prot | 2010 |
Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzamides; Child; Cohort Studies; Disease-Free Surv | 2011 |
Chronic myelogenous leukemia in the chronic phase with lymph node swelling which represented extramedullary involvement composed of cells at different stages of maturation.
Topics: Benzamides; Blast Crisis; Fatal Outcome; Humans; Hydroxyurea; Imatinib Mesylate; Leukemia, Myeloid, | 2011 |
Blood consult: high Sokal risk chronic myeloid leukemia and suboptimal response.
Topics: Antineoplastic Agents; Benzamides; Dasatinib; Humans; Hydroxyurea; Imatinib Mesylate; Leukemia, Myel | 2011 |
Normal intrinsic Th1/Th2 balance in patients with chronic phase chronic myeloid leukemia not treated with interferon-alpha or imatinib.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Cytokines; Enzyme Inhibitors; Female; Humans; Hydrox | 2003 |
Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate.
Topics: Acute Disease; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamid | 2005 |
Hydroxyurea and splenic irradiation-induced tumour lysis syndrome: a case report and review of the literature.
Topics: Aged; Allopurinol; Antineoplastic Agents; Humans; Hydroxyurea; Leukemia, Myeloid, Chronic-Phase; Mal | 2005 |
Gene expression analysis identifies a genetic signature potentially associated with response to alpha-IFN in chronic phase CML patients.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Cytarabine; Fusion Proteins, bcr-abl; Gene Ex | 2007 |
Cocaine abuse may influence the response to imatinib in CML patients.
Topics: Adult; Antineoplastic Agents; Benzamides; Cocaine; Cocaine-Related Disorders; Cytochrome P-450 CYP3A | 2007 |
Mobilization of Philadelphia-negative peripheral blood mononuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim).
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Filgrastim; Fus | 1996 |
Abnormal kinetics of colony formation by erythroid burst-forming units (BFU-E) in chronic myeloid leukaemia.
Topics: Bone Marrow; Cell Differentiation; Cell Division; Erythroid Precursor Cells; Humans; Hydroxyurea; Le | 1996 |
t(3;21) following peripheral blood stem cell transplantation in chronic phase chronic myeloid leukaemia.
Topics: Adult; Antineoplastic Agents; Chromosome Banding; Chromosomes, Human, Pair 21; Chromosomes, Human, P | 1997 |
Persisting bone marrow aplasia following interferon-alpha combined with ara-C for chronic myelogenous leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Dose-Response Relati | 1999 |
BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase.
Topics: Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Bone Marrow Purging; Cell Adhesion; Cell Separ | 2000 |
Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
Topics: Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Fusion Proteins, bcr-abl; Humans; Hydroxyurea; | 2000 |
Interferon-alpha therapy increases type I insulin-like growth factor receptors expression on lymphoid cells from patients with chronic myelogenous leukemia.
Topics: Adolescent; Adult; Antineoplastic Agents; B-Lymphocytes; Child; Female; Flow Cytometry; Granulocytes | 2001 |
Autologous reconstitution combined with durable leukemic remission after allogeneic BMT for CML: absence of persistence of a donor-derived T cell effector population.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Bone Marrow T | 2001 |
Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Benzamides; Bone Marrow Transplantation; C | 2001 |
Multiple longitudinal pigmented nail bands during hydroxyurea therapy.
Topics: Aged; Female; Humans; Hydroxyurea; Leukemia, Myeloid, Chronic-Phase; Melanocytes; Nail Diseases; Pig | 1992 |
Non-aggressive therapy for chronic myeloid leukaemia in blastic transformation.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Prot | 1992 |
The role of the MDR-1/P-170 mechanism in the development of multidrug resistance in chronic myeloid leukemia.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Busulfan; Drug Resistance; Ge | 1990 |
Hydroxyurea hypersensitivity reaction.
Topics: Aged; Drug Hypersensitivity; Humans; Hydroxyurea; Leukemia, Myeloid, Chronic-Phase; Male | 1989 |